131 related articles for article (PubMed ID: 9138734)
21. The I1-imidazoline-binding site is a functional receptor mediating vasodepression via the ventral medulla.
Ernsberger P; Haxhiu MA
Am J Physiol; 1997 Nov; 273(5):R1572-9. PubMed ID: 9374796
[TBL] [Abstract][Full Text] [Related]
22. The I(1)-imidazoline receptor in PC12 pheochromocytoma cells reverses NGF-induced ERK activation and induces MKP-2 phosphatase.
Edwards L; Ernsberger P
Brain Res; 2003 Aug; 980(1):71-9. PubMed ID: 12865160
[TBL] [Abstract][Full Text] [Related]
23. The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C.
Amtmann E
Drugs Exp Clin Res; 1996; 22(6):287-94. PubMed ID: 9034754
[TBL] [Abstract][Full Text] [Related]
24. Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells.
Singh AT; Radeff JM; Kunnel JG; Stern PH
Biochim Biophys Acta; 2000 Sep; 1487(2-3):201-8. PubMed ID: 11018472
[TBL] [Abstract][Full Text] [Related]
25. Centrally acting drug moxonidine decreases reactive oxygen species via inactivation of the phosphoinositide-3 kinase signaling in the rostral ventrolateral medulla in hypertensive rats.
Wang YK; Yu Q; Tan X; Wu ZT; Zhang RW; Yang YH; Yuan WJ; Hu QK; Wang WZ
J Hypertens; 2016 May; 34(5):993-1004. PubMed ID: 26886567
[TBL] [Abstract][Full Text] [Related]
26. Harmane produces hypotension following microinjection into the RVLM: possible role of I(1)-imidazoline receptors.
Musgrave IF; Badoer E
Br J Pharmacol; 2000 Mar; 129(6):1057-9. PubMed ID: 10725251
[TBL] [Abstract][Full Text] [Related]
27. Imidazoline receptors in the heart: a novel target and a novel mechanism of action that involves atrial natriuretic peptides.
Mukaddam-Daher S; Gutkowska J
Braz J Med Biol Res; 2004 Aug; 37(8):1239-45. PubMed ID: 15273826
[TBL] [Abstract][Full Text] [Related]
28. Evidence for the role of phosphatidylcholine-specific phospholipase C in sustained hypoxic pulmonary vasoconstriction.
Strielkov IV; Kizub IV; Khromov AS; Soloviev AI
Vascul Pharmacol; 2013 Apr; 58(4):292-8. PubMed ID: 23416246
[TBL] [Abstract][Full Text] [Related]
29. Moxonidine: a new antiadrenergic antihypertensive agent.
Prichard BN; Graham BR; Owens CW
J Hypertens Suppl; 1999 Aug; 17(3):S41-54. PubMed ID: 10489098
[TBL] [Abstract][Full Text] [Related]
30. Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine.
Chan CK; Burke SL; Zhu H; Piletz JE; Head GA
Neuroscience; 2005; 132(4):991-1007. PubMed ID: 15857704
[TBL] [Abstract][Full Text] [Related]
31. Methylmercury-induced toxicity is mediated by enhanced intracellular calcium through activation of phosphatidylcholine-specific phospholipase C.
Kang MS; Jeong JY; Seo JH; Jeon HJ; Jung KM; Chin MR; Moon CK; Bonventre JV; Jung SY; Kim DK
Toxicol Appl Pharmacol; 2006 Oct; 216(2):206-15. PubMed ID: 16854443
[TBL] [Abstract][Full Text] [Related]
32. D609-phosphatidylcholine-specific phospholipase C inhibitor attenuates thapsigargin-induced sodium influx in human lymphocytes.
Nofer JR; Junker R; Seedorf U; Assmann G; Zidek W; Tepel M
Cell Signal; 2000 May; 12(5):289-96. PubMed ID: 10822169
[TBL] [Abstract][Full Text] [Related]
33. Effect of D609 on phosphatidylcholine metabolism in the nuclei of LA-N-1 neuroblastoma cells: a key role for diacylglycerol.
Antony P; Farooqui AA; Horrocks LA; Freysz L
FEBS Lett; 2001 Nov; 509(1):115-8. PubMed ID: 11734217
[TBL] [Abstract][Full Text] [Related]
34. Commissural nucleus of the solitary tract regulates the antihypertensive effects elicited by moxonidine.
Totola LT; Alves TB; Takakura AC; Ferreira-Neto HC; Antunes VR; Menani JV; Colombari E; Moreira TS
Neuroscience; 2013 Oct; 250():80-91. PubMed ID: 23850502
[TBL] [Abstract][Full Text] [Related]
35. New 2-Aminothiazoline derivatives lower blood pressure of spontaneously hypertensive rats (SHR) via I
Ferreira RB; de Oliveira MG; Antunes E; Almeida WP; Ibrahim BM; Abdel-Rahman AA
Eur J Pharmacol; 2016 Nov; 791():803-810. PubMed ID: 27729248
[TBL] [Abstract][Full Text] [Related]
36. Novel targets and techniques in imidazoline receptor research.
Musgrave IF; Hughes RA
Ann N Y Acad Sci; 1999 Jun; 881():301-12. PubMed ID: 10415931
[TBL] [Abstract][Full Text] [Related]
37. Priming of alveolar macrophage respiratory burst by H(2)O(2) is prevented by phosphatidylcholine-specific phospholipase C inhibitor Tricyclodecan-9-yl-xanthate (D609).
Girón-Calle J; Srivatsa K; Forman HJ
J Pharmacol Exp Ther; 2002 Apr; 301(1):87-94. PubMed ID: 11907161
[TBL] [Abstract][Full Text] [Related]
38. Pharmacology of moxonidine: an I1-imidazoline receptor agonist.
Ernsberger P
J Cardiovasc Pharmacol; 2000; 35(7 Suppl 4):S27-41. PubMed ID: 11346217
[TBL] [Abstract][Full Text] [Related]
39. Compound D609 inhibits phorbol ester-stimulated phospholipase D activity and phospholipase C-mediated phosphatidylethanolamine hydrolysis.
Kiss Z; Tomono M
Biochim Biophys Acta; 1995 Oct; 1259(1):105-8. PubMed ID: 7492608
[TBL] [Abstract][Full Text] [Related]
40. Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms.
Walter M; Reinecke H; Gerdes U; Nofer JR; Höbbel G; Seedorf U; Assmann G
J Clin Invest; 1996 Nov; 98(10):2315-23. PubMed ID: 8941649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
